A. B. Gurung, Mylliemngap, B. J., Bhattacharjee, A., Ali, M. A., and Al-Hemaid, F. M. A.,
“Interactome analysis and design of inhibitors against selected protein targets of Ser/Thr protein kinase (STPK) signaling pathways in Mycobacterium tuberculosis H37Rv”, vol. 14, pp. 10390-10403, 2015.
Tuberculosis continues to be a major cause of mortality worldwide despite significant advances in chemotherapy and development of the BCG vaccine. Although curable, the tuberculosis treatment period (6-9 months) presents many concerns, including patient noncompliance and the development of drug toxicity and drug resistance.